Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | NPC1 | O15118 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | RAB9A | P51151 | 4/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.57 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.57 |
| ▸ | RELA | Q04206 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | MAOB | P27338 | 1/20 | 0.56 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL999704 | 0.89 | TSHR (0.61) | ALDH1A1NPC1MAPTRAB9AKMT2A | |
| SCHEMBL29383324 | 0.89 | TSHR (0.61) | ALDH1A1NPC1MAPTRAB9AKMT2A | |
| SCHEMBL19243173 | 0.84 | ALDH1A1 (0.65) | ALDH1A1MAPK1NPC1MAPTRAB9A | |
| SCHEMBL7075198 | 0.84 | ALDH1A1 (0.65) | ALDH1A1MAPK1NPC1MAPTRAB9A | |
| SCHEMBL28963614 | 0.82 | ALDH1A1 (0.62) | ALDH1A1MAPK1NPC1MAPTRAB9A | |
| SCHEMBL10728217 | 0.82 | ALDH1A1 (0.62) | ALDH1A1MAPK1NPC1MAPTRAB9A | |
| SCHEMBL10057828 | 0.81 | ALDH1A1 (0.66) | ALDH1A1MAPK1NPC1MAPTRAB9A | |
| SCHEMBL5416122 | 0.79 | ALDH1A1 (0.69) | ALDH1A1MAPK1NPC1MAPTRAB9A | |
| SCHEMBL31322028 | 0.79 | MAPT (0.68) | ALDH1A1MAPK1NPC1MAPTRAB9A | |
| SCHEMBL11095416 | 0.79 | MAPT (0.68) | ALDH1A1MAPK1NPC1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110938845-A | Plating solution for electrolytic tinning | 上村工业株式会社 | 2020-03-31 | — | — | CN | claimed |
| US-20200095698-A1 | ELECTROLYTIC TIN PLATING SOLUTION | C. UYEMURA & CO., LTD. (JP) | 2020-03-26 | — | — | US | claimed |
| CN-110938845-A | Plating solution for electrolytic tinning | 上村工业株式会社 | 2020-03-31 | — | — | CN | disclosed |
| US-20200095698-A1 | ELECTROLYTIC TIN PLATING SOLUTION | C. UYEMURA & CO., LTD. (JP) | 2020-03-26 | — | — | US | disclosed |
| US-9359277-B2 | Compositions and processes of preparing and using the same | PURDUE RESEARCH FOUNDATION (US) | 2016-06-07 | — | — | US | disclosed |
| US-9359277-B2 | Compositions and processes of preparing and using the same | PURDUE RESEARCH FOUNDATION (US) | 2016-06-07 | — | — | US | disclosed |
| US-20140039182-A1 | COMPOSITIONS AND PROCESSES OF PREPARING AND USING THE SAME | PURDUE RESEARCH FOUNDATION | 2014-02-06 | — | — | US | disclosed |
| US-20140039182-A1 | COMPOSITIONS AND PROCESSES OF PREPARING AND USING THE SAME | PURDUE RESEARCH FOUNDATION | 2014-02-06 | — | — | US | disclosed |
| WO-2012129384-A2 | COMPOSITIONS AND PROCESSES OF PREPARING AND USING THE SAME | PURDUE RESEARCH FOUNDATION (US) | 2012-09-27 | — | — | WO | disclosed |
| WO-2011009826-A2 | NOVEL CHALCONE DERIVATIVES WITH CYTOTOXIC ACTIVITY | ADAMED Sp.z o.o. (PL) | 2011-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140039182-A1 | COMPOSITIONS AND PROCESSES OF PREPARING AND USING THE SAME | DBF4, FAU, DHX29 | ALDH1A1 2102/4885MAPK1 2698/4885NPC1 422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.